Scientific Research Solutions

---

KINETIC’s Preclinical Scientific Research Team comprises highly skilled PhD-level experts who are leaders in their own respective field who support preclinical research strategies and activities of biotechnology companies, pharmaceutical multinationals, and academic institutions. We provide early consulting solutions ranging from the design and development of preclinical strategies for novel preclinical assets to supporting studies to achieve IND-enabling milestones. 

Our Preclinical Scientific Research solutions and services include:

•  ADME (Absorption Distribution Metabolism Excretion) Protocol /  Study Report 
•  Bioanalytical Study Protocol / Study Report 
•  Biopharmaceutical Study Protocol / Study Report
•  Clinical Pharmacology Study Protocol / Study Report (Dose Optimisation and Exposure-Response Analysis)
•  Contract Research Vendor Selection and Management 
•  Cytoxicity Study Protocol / Study Report 
•  DMPK (Drug Metabolism and Pharmacokinetics) Protocol / Study Report
•  Health Economic Outcomes Study Design / Study Report 
•  Immunogenicity Study Protocol / Study Report
•  In-Vitro Pharmacology / In-Vivo Pharmacology
•  Preclinical Strategy Evaluations 
•  Pharmacokinetic and Pharmacodynamic Study Protocol / Study Report  (Modelling and Simulation/Population PK/PD)
•  Proof-of-Concept (PoC) Study Protocol / Study Report
•  Proteomics / High Throughput Screening
•  Scientific Publications: Abstract Poster Manuscript Presentation
•  Target Validation Study Protocol / Study Report
•  Toxicology Study Protocol / Study Report (In Vivo/In Vitro)

We also undertake Market Intelligence and Competitive Intelligence research including designing, developing and executing qualitative studies for products, pipelines and portfolios 

KINETIC’s Scientific Research Team provide robust scientific advice, design compelling scientific strategies and develop preclinical research solutions that facilitate data generation for successful product development.